In a significant advancement for biomedical research, Qdrant has announced that its cloud infrastructure is powering Sapu’s AI research platform, which can now index and query all 28 million abstracts from PubMed in a single searchable collection. This capability is designed to accelerate discovery workflows for hard-to-treat cancers, according to a blog post by Daniel Azoulai on the Qdrant website.
Sapu, an early-stage biopharmaceutical company, developed the platform from an early prototype into a production-scale system supporting scientific literature review, standard operating procedure retrieval, and AI-assisted research authorship. The company reports that the platform has already contributed to seven peer-reviewed research papers and is used broadly across its research operations. This integration highlights the growing importance of AI and vector search in streamlining biomedical research.
The platform’s evolution is part of Sapu’s broader strategy to expand its capabilities. The company is partnering with Techforce on a robotics initiative and evaluating edge deployments for secure, air-gapped laboratory environments. Qdrant’s hybrid vector and metadata retrieval architecture is central to enabling the scale, speed, and flexibility required for these next-stage applications. As noted in the post, Qdrant’s technology allows for efficient indexing and retrieval of high-dimensional data, which is crucial for handling the vast amount of scientific literature.
Qdrant, a developer-focused provider of vector search technology, was founded after co-founders André Zayarni and Andrey Vasnetsov identified a gap in existing vector similarity search tools. The company has grown from an open-source GitHub project into an enterprise-grade platform supporting startups and large organizations. Built in Rust, Qdrant has surpassed 250 million downloads and earned more than 29,000 GitHub stars, with a global team of over 100 employees across 20-plus countries. The company offers both open-source and managed cloud vector search solutions, giving developers precise control over indexing, search, and retrieval.
The implications of this announcement extend beyond Sapu’s research. By enabling efficient querying of all PubMed abstracts, Qdrant’s technology could significantly reduce the time researchers spend on literature review, potentially accelerating the pace of cancer research and other biomedical discoveries. For more information about Qdrant’s vector search capabilities, visit https://qdrant.tech.
This development underscores the critical role of AI infrastructure in modern research. As AI platforms become more integrated into scientific workflows, technologies like Qdrant’s vector search are poised to become essential tools for managing and extracting insights from massive datasets. The ability to index and search 28 million abstracts in one place represents a leap forward in making biomedical literature more accessible and actionable for researchers worldwide.
This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Qdrant Cloud Powers Sapu AI Platform Indexing 28 Million PubMed Abstracts to Accelerate Cancer Research.